Sign in
4

Changes in Ownership

Shuttle Pharmaceuticals Holdings, Inc. Filed Acc 0001493152-24-040614

Chief Scientific Officer acquired 598 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jung Mira Chief Scientific Officer 2024-05-01 Grant or award −598 $11.28 $6,745 135,715 D: show line 1 in the form
Loading xslF345X05/ownership.xml…